|
|
|
|
Programs: Urology
|
|
 |
|
Industrial Partners:
CADMIT, Canadian Prostate Center,
GE-Canada,
Healthtronics
Institutional Partners:
UHN, RRI, SWHSC
Principal Investigators:
Sherar, Peters, Fenster, Kucharczyk, Bronskill, Cunningham
|
Opportunity
A major clinical focus is the development of new minimally invasive methods for treating prostate cancer. The need for improved therapy driven by the large numbers of men diagnosed with prostate cancer each year (> 40,000 per year in Canada) and the relatively high rate of complications and treatment failure associated with current treatment options such as radiation therapy and surgery. New minimally invasive technologies developed in OCITS that result in equivalent or better outcome with fewer complications have the potential to help many future patients and capture very large markets. A second opportunity is in the area of kidney stone analysis to aid shockwave rate of complications and treatment failure associated with current treatment options such as radiation therapy and surgery. New minimally invasive technologies developed in OCITS that result in equivalent or better outcome with fewer complications have the potential to help many future patients and capture very large markets. A second opportunity is in the area of kidney stone analysis to aid shockwave lithotripsy using a new imaging technique called "coherent-scatter computed tomography" (CSCT).
|
|
